What is Cognetivity Neurosciences Operating Cash Flow per Share?
Cognetivity Neurosciences's operating cash flow per share for the
three
months ended in Oct. 2023 was $0.00.
Cognetivity Neurosciences's operating cash flow per share for the trailing twelve months (TTM) ended in Oct. 2023 was $-0.03.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -13.50% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -9.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.
The historical rank and industry rank for Cognetivity Neurosciences's Operating Cash Flow per Share or its related term are showing as below:
CGNSF'
s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -72.4 Med: -14.9 Max: 20
Current: -13.5
During the past 7 years, Cognetivity Neurosciences's highest 3-Year average Operating Cash Flow per Share Growth Rate was 20.00% per year. The lowest was -72.40% per year. And the median was -14.90% per year.
CGNSF's 3-Year OCF Growth Rate is ranked worse than 78.47% of 497
companies
in the Healthcare Providers & Services industry
Industry Median: 9.3
vs CGNSF: -13.50
Cognetivity Neurosciences Operating Cash Flow per Share Historical Data
The historical data trend for Cognetivity Neurosciences's Operating Cash Flow per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Cognetivity Neurosciences Operating Cash Flow per Share Chart
Competitive Comparison of Cognetivity Neurosciences's Operating Cash Flow per Share
For the Health Information Services subindustry, Cognetivity Neurosciences's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cognetivity Neurosciences's Price-to-Operating-Cash-Flow Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Cognetivity Neurosciences's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Cognetivity Neurosciences's Price-to-Operating-Cash-Flow falls into.
Cognetivity Neurosciences Operating Cash Flow per Share Calculation
Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.
Cognetivity Neurosciences's Operating Cash Flow per Share for the fiscal year that ended in Jan. 2023 is calculated as
Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Oct. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.03
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cognetivity Neurosciences Operating Cash Flow per Share Related Terms
Thank you for viewing the detailed overview of Cognetivity Neurosciences's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Cognetivity Neurosciences (Cognetivity Neurosciences) Business Description
Cognetivity Neurosciences Ltd is a technology company developing a cognitive testing platform, the Integrated Cognitive Assessment (ICA), for use in medical, commercial, and consumer environments for potentially allowing early diagnosis of dementia. The Company is considered operating in one segment for development of the ICA platform. Its geographical areas include Canada, United Kingdom and Dubai.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CGNSF has been successfully added to your 